The not-so innocent bystander: the microenvironment as a therapeutic target in cancer.
about
New highlights on stroma-epithelial interactions in breast cancer.Imaging and quantifying the dynamics of tumor-associated proteolysis.Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breastIncreased blood clotting, microvascular density, and inflammation in eotaxin-secreting tumors implanted into mice.Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironmentClassical radiation biology dogma, bystander effects and paradigm shifts.Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III, and IV.Radiation-induced bystander effects: are they good, bad or both?Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy.New rationales for using TGFbeta inhibitors in radiotherapy.TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.Transforming growth factor-beta in breast cancer: too much, too late.Stromal Activation by Tumor Cells: An in Vitro Study in Breast CancerThe molecular genetics of breast cancer and targeted therapyPost-transplantation malignancy: a cell autonomous mechanism with implications for therapy.Therapeutic targets in malignant glioblastoma microenvironmentProteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions.Radiation-induced bystander effects: evidence for an adaptive response to low dose exposures?Induction and progression of cholangiofibrosis in rat liver injured by oral administration of furan.Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer.
P2860
Q24797078-35AE0395-C90A-4CDD-AA48-6D9F63FBF2C9Q30497465-8E4B6282-F0ED-4ED0-BE8E-848F199BDE94Q31039477-1897F273-F97E-4782-8EF3-FA2E9B5F3706Q33753945-F750887B-028B-413F-8024-E918FA93C55FQ35102973-D75AB465-C12A-4424-817E-A6EE411CCEABQ35597185-72FBDFC9-7F6C-4163-9FF8-614CFFB5A050Q35740442-A10121D2-F4D9-45F7-9102-3177A3597A40Q35762194-12E7B409-5305-4D1A-8F72-CE8082171381Q36210552-4A35B1E2-1937-4095-8538-AC0034AA7C80Q36318551-114BF78B-3555-4FF5-955C-8FC2318F4A02Q37024029-A44D33B2-CD28-47E6-AEA2-9A94B02910F2Q37048061-98883447-659A-47EE-A3A7-BB6B80CB1BCDQ37205559-2600C975-354C-4144-9A31-30F231E91A63Q37214284-801096F4-E28A-4A54-A328-67ADCD5FC073Q37290512-C665282A-1279-47C3-B55E-FF52BF91315BQ37348173-A9D0C4AF-6AE7-46D4-BDAB-FB1B95DC5A6CQ37493413-FE9C8DE7-5F20-4EB2-9027-EC246DE42350Q37636855-17981545-32F3-4F65-8A71-2C784D01C6F2Q40708511-90F65DEF-1689-42EF-A4DC-169726325DA4Q43128717-51E4DF18-6D59-4BDC-9A77-2FF8B4294504Q53275913-88634492-A790-44DD-881B-99CB25229A33
P2860
The not-so innocent bystander: the microenvironment as a therapeutic target in cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The not-so innocent bystander: the microenvironment as a therapeutic target in cancer.
@ast
The not-so innocent bystander: the microenvironment as a therapeutic target in cancer.
@en
type
label
The not-so innocent bystander: the microenvironment as a therapeutic target in cancer.
@ast
The not-so innocent bystander: the microenvironment as a therapeutic target in cancer.
@en
prefLabel
The not-so innocent bystander: the microenvironment as a therapeutic target in cancer.
@ast
The not-so innocent bystander: the microenvironment as a therapeutic target in cancer.
@en
P2860
P356
P1476
The not-so innocent bystander: the microenvironment as a therapeutic target in cancer.
@en
P2093
Anna C Erickson
Mary Helen Barcellos-Hoff
P2860
P356
10.1517/14728222.7.1.71
P407
P577
2003-02-01T00:00:00Z